Result of AGM

Summary by AI BETAClose X

Spire Healthcare Group PLC announced that all resolutions proposed at its 2026 Annual General Meeting were passed by shareholders. The total number of shares in issue is 402,759,599, with approximately 81% of the issued share capital voted. Resolutions generally saw very high approval rates, with votes for ranging from 96.75% to 99.94% of votes cast, and votes against between 0.06% and 3.25%.

Disclaimer*

Spire Healthcare Group PLC
14 May 2026
 

SPIRE HEALTHCARE GROUP PLC (the 'Company')                                          14 May 2026

 

Results of 2026 Annual General Meeting

 

Spire Healthcare Group plc (LSE: SPI) ('Spire Healthcare', 'the Group' or 'the Company'), a leading independent healthcare group in the UK, announces that all resolutions proposed to shareholders at the twelfth annual general meeting of the Company held at 11.00am on 14 May 2026 at 3 Dorset Rise, London EC4Y 8EN (2026 AGM) were passed by the requisite majority on a poll.

 

The following table shows the votes cast for and against each resolution and the number of votes withheld:

 

Resolutions

Votes for

% of votes for

Votes against

% of votes against

Total votes cast

% of ISC voted

Votes withheld

1

325,963,695

99.94

202,861

0.06

326,166,556

80.98%

279,154

2

323,091,544

98.98

3,313,403

1.02

326,404,947

81.04%

40,763

3

326,147,013

99.91

284,396

0.09

326,431,409

81.05%

14,301

4

323,008,673

98.99

3,302,513

1.01

326,311,186

81.02%

134,524

5

324,230,382

99.35

2,129,091

0.65

326,359,473

81.03%

86,237

6

324,267,138

99.37

2,040,909

0.63

326,308,047

81.02%

137,663

7

322,268,988

98.75

4,070,956

1.25

326,339,944

81.03%

105,766

8

322,092,226

98.70

4,229,666

1.30

326,321,892

81.02%

123,818

9

324,259,208

99.38

2,037,628

0.62

326,296,836

81.02%

148,874

10

324,272,415

99.36

2,074,165

0.64

326,346,580

81.03%

99,130

11

324,298,633

99.37

2,047,829

0.63

326,346,462

81.03%

99,248

12

324,293,095

99.38

2,019,159

0.62

326,312,254

81.02%

133,456

13

322,225,898

98.75

4,087,531

1.25

326,313,429

81.02%

132,281

14

323,020,966

98.99

3,286,823

1.01

326,307,789

81.02%

137,921

15

324,406,392

99.41

1,910,246

0.59

326,316,638

81.02%

129,072

16

324,753,734

99.51

1,604,043

0.49

326,357,777

81.03%

87,843

17

315,813,077

96.75

10,604,458

3.25

326,417,535

81.05%

28,175

18

318,997,526

97.73

7,408,100

2.27

326,405,626

81.04%

40,084

19*

322,766,156

98.89

3,631,549

1.11

326,397,705

81.04%

48,005

20*

320,179,433

98.09

6,234,297

1.91

326,413,730

81.04%

31,980

21*

325,797,114

99.81

621,805

0.19

326,418,919

81.05%

26,791

22*

323,900,058

99.25

2,437,243

0.75

326,337,301

81.03%

108,409

 

*Special Resolution

 

Notes:

i)          Any proxy appointments which gave discretion to the Chairman have been included in votes "for". The total number of shares in issue (ISC) is 402,759,599.

ii)          A "vote withheld" is not a vote in law and is not counted in the calculation of the votes "for" and "against" a resolution.

iii)         All percentages are shown to two decimal places.

iv)         To view the full wording of the resolutions, please refer to the Notice of 2026 AGM on the Company's website at investors.spirehealthcare.com.

This information will also be made available on the Company's website at investors.spirehealthcare.com.

Copies of the resolutions passed as special resolutions (resolutions 19 to 22 inclusive) will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Mantraraj Budhdev

Group General Counsel, Chief People Officer and Company Secretary

14 May 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings